scientists allege that the efficacy tests for the measles, mumps, rubella vaccine (MMR) were faked.
The scientists allege that the efficacy tests for the measles, mumps, rubella vaccine (MMR) were faked. The document was unsealed in June, 2012.
This is a major federal case alleging fraud in vaccine testing; it encapsulates how medical research can be manipulated to achieve desired results, and why it may be wise to question the integrity and the validity of “science-based medicine.”
The suit charges that Merck knew its measles, mumps, rubella (MMR) vaccine was less effective than the purported 95% level, and it alleges that senior management was aware and also oversaw testing that concealed the actual effectiveness. According to the lawsuit, Merck began a sham testing program in the late 1990’s to hide the declining efficacy of the vaccine. The objective of the fraudulent trials was to “report efficacy of 95% or higher regardless of the vaccine’s true efficacy.”
According to Krahling and Wlochowski’s complaint, they were threatened with jail were they to alert the FDA to the fraud being committed.
In January 31, 2016, the court ordered that discovery, the process of gathering evidence, must be completed by 1 March 2017, over a year from now. The court also ordered that expert discovery needs to be completed by 31 October 2017.
Other motions must be filed by 20 December 2017. A motion for class action certification must be filed by 1 March 2018; and Merck must file its opposition to class certification by 5 April 2018.
The plaintiffs charge that Merck defrauded the U.S. for more than a decade by faking a vaccine efficacy rate of 95% even though the real rate was significantly lower.
“As the single largest purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchasers), the United States is by far the largest financial victim of Merck’s fraud. But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps. And while this is a disease the CDC targeted ts the single largest purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchasers), the United States is byo eradicate by now, the failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur,” the suit alleges. (Forbes June 6, 2012)
According to the suit, the objective of the fraudulent trials was to “report efficacy of 95% or higher regardless of the vaccine’s true efficacy.”
“For the new testing method, the children’s blood was tested for its ability to neutralize the virus using the vaccine strain virus, instead of the wild type strain that is much more infective, and the one that your children would most likely catch… But still it was not 95% effective. In order to make the blood pass the test, antibodies from rabbits was added. The addition of rabbit antibody increased the efficacy to 100%. But that was not the end, because the test has to be done on pre-vaccine blood and post-vaccine blood.